D-0659-2020 Class II Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

FDA drug recall D-0659-2020 was initiated by Sun Pharmaceutical Industries, Inc. on Dec 26, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance. The recall status is terminated (terminated Oct 22, 2020). Affected quantity: 384/100 count bottles.

Recall details

Product Type
Drugs
Report Date
Jan 22, 2020
Initiation Date
Dec 26, 2019
Termination Date
Oct 22, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
384/100 count bottles

Product description

Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (NDC 62756-521-69) and b) 100 count bottles, (NDC 62756-521-88), Rx only, Sun Pharma, Cranbury, NJ

Reason for recall

Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.

Distribution pattern

Product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.

Code information

a) JKU1939A, JKU1940A, JKU1940B, exp. date 04/2022 and b) JKT4175A, exp. date 11/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0659-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0659-2020. Report a data issue: hello@regdatalab.com.